Reference
Hunyady B, et al. Ombitasvir/paritaprevir/ritonavir + dasabuvir + ribavirin in HCV genotype 1 infected patients who failed previous protease inhibitor therapy. Clinical and Experimental Hepatology 4: 83-90, No. 2, 2018. Available from: URL: http://doi.org/10.5114/ceh.2018.75957 - Hungary
Rights and permissions
About this article
Cite this article
Antivirals. Reactions Weekly 1715, 41 (2018). https://doi.org/10.1007/s40278-018-50589-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-50589-7